PLD
45
-5
ROP
53
-9
AN
50
-5
DIS
85
3
CCI
30
-11
GRMN
67
-4
M
31
-3
RIG
43
-7
BDX
56
10
SHW
62
-6
TXN
43
-5
PBI
56
-2
XOM
42
-6
WYNN
36
-5
EXR
57
2
CMS
60
2
SLB
52
-3
IPG
34
-9
GILD
47
-8
PGR
59
-3
PLD
45
-5
ROP
53
-9
AN
50
-5
DIS
85
3
CCI
30
-11
GRMN
67
-4
M
31
-3
RIG
43
-7
BDX
56
10
SHW
62
-6
TXN
43
-5
PBI
56
-2
XOM
42
-6
WYNN
36
-5
EXR
57
2
CMS
60
2
SLB
52
-3
IPG
34
-9
GILD
47
-8
PGR
59
-3
Financhill
Back

Insperity Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
26

NSP
Insperity

Last Price:
73.37
Seasonality Move:
1.94%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.56
Seasonality Move:
17.03%
Sell
26
Insperity (NSP) is a Sell

Is Insperity a Buy, Sell or Hold?

  • The current Insperity [NSP] share price is $73.14. The Score for NSP is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • NSP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NSP Stock Price Chart

What is Insperity's stock price today?

  • The Insperity share price today is $73.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NSP is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

NSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.72 Sell
Relative Strength Index (14 RSI): 34.77 Sell
Chaikin Money Flow: -252623 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.78 - 86.68) Sell
Bollinger Bands (100): (82.76 - 95.86) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

NSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 78.37 Sell
20-day SMA: 80.09 Sell
50-day SMA: 84.57 Sell
200-day SMA: 95.44 Sell
8-day EMA: 77.07 Sell
20-day EMA: 79.77 Sell
50-day EMA: 83.97 Sell
200-day EMA: 93.98 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Insperity Earnings Growth & NSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.86 per share, and an increase next year of $0.14 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Insperity Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):